Filing Details
- Accession Number:
- 0001209191-18-047055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-16 16:26:24
- Reporting Period:
- 2018-08-14
- Accepted Time:
- 2018-08-16 16:26:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1322505 | Albireo Pharma Inc. | ALBO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1676880 | Wilfred Harold Ronald Cooper | C/O Albireo Pharma Inc. 10 Post Office Square, Suite 502 South Boston MA 02109 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-14 | 588 | $31.63 | 6,534 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-14 | 200 | $32.50 | 6,734 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018.
- This transaction was executed in multiple trades at prices ranging from $31.39to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
